Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Chubb
Merck
McKesson
Deloitte
Fuji
UBS
Queensland Health

Generated: May 25, 2018

DrugPatentWatch Database Preview

WINSTROL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Winstrol patents expire, and what generic alternatives are available?

Winstrol is a drug marketed by Lundbeck Inc and is included in one NDA.

The generic ingredient in WINSTROL is stanozolol. There are two drug master file entries for this compound. Additional details are available on the stanozolol profile page.
Summary for WINSTROL
Drug patent expirations by year for WINSTROL
Medical Subject Heading (MeSH) Categories for WINSTROL
Synonyms for WINSTROL
(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5-dien-17-ol
(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0;{2,10}.0;{4,8}.0;{14,18}]icosa-4(8),5-dien-17-ol
(1S,2S,10S,13R,14S,17S,18S)-2,17,18-TRIMETHYL-6,7-DIAZAPENTACYCLO[11.7.0.0(2),(1)?.0?,?.0(1)?,(1)?]ICOSA-4(8),5-DIEN-17-OL
(1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
(1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
(5a,17b)-17-methyl-2'H-Androst-2-eno[3,2-c]pyrazol-17-ol
1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol
1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-Hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol
1'H-Androstano(3,2-c)pyrazol-17-ol, 17-methyl-, (5-alpha,17-beta)-
10418-03-8
17-beta-Hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole
17-Methyl-1'H-5alpha-androstano[3,2-c]pyrazol-17beta-ol
17-Methyl-2'H-5alpha-androst-2-eno(3,2-c)pyrazol-17beta-ol
17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol
17-Methyl-5alpha-androstano(3,2-c)pyrazol-17beta-ol
17-Methyl-pyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol
17-Methylpyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
17?-Methyl-5?-androstano[3,2-c]pyrazol-17?-ol
17966-55-1
17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole
17alpha-Methyl-17beta-hydroxy-5alpha-androst-2-eno(3,2-c)-pyrazole
17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole
17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole
17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole
17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole
17beta-Hydroxy-17alpha-methyl-androstano(3,2-c)pyrazole
2,3-(4',3'-Pyrazolo)-5alpha-androstan-17beta-ol, 17-methyl-
2,3'-Pyrazolo)-5.alpha.-androstan-17.beta.-ol, 17-methyl-
2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI)
2'H-5alpha-Androst-2-eno(3,2-c)pyrazol-17beta-ol, 17-methyl-
2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
302-96-5
302-96-5 (Alternate Registry Number)
418S038
4R1VB9P8V3
5alpha-Androstane-17alpha-methyl-17beta-ol-[3,2-c]pyrazole
69353-49-7
875293-72-4
AB00443942-03
AB00443942-05
AC-16140
AC1L18QU
AC1Q59E2
AK326187
AKOS005067278
AM84316
Ambap10418-03-8
Anabol
Androstanazol
Androstanazole
Androstanazole (VAN)
Androstanazolestanazol
BC210011
C07311
C21H32N2O.CH4
CAS-10418-03-8
CCG-101186
CCG-220452
CHEBI:9249
CHEMBL2079587
CPD000058878
CS-4363
Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
Cyclopenta[7,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
Cyclopenta[7,8]phenanthro-[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4
Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 2'H-androst-2-eno[3,2-c]pyrazol-17-ol deriv.
D00444
D08QKJ
DB06718
DSSTox_CID_24128
DSSTox_GSID_44128
DSSTox_RID_97564
DTXSID3044128
EBD2201785
EINECS 233-894-8
Estanozolol
Estanozolol [INN-Spanish]
Estazol
HMS2052H11
HMS2090P03
HSDB 3185
HY-B0899
I06-2218
LS-19415
LS-19530
MCULE-6473940948
Methylstanazol
MLS001424321
NC00436
NCGC00344550-01
NSC 233046
NSC 43193
NSC-43193
NSC43193
PL040294
SCHEMBL44099
SCHEMBL44100
SMR000058878
Stanazolol
stanozol
Stanozolo
Stanozolo [DCIT]
stanozolol
Stanozolol (1'H form)
Stanozolol (2'H form)
Stanozolol (JAN/USP/INN)
Stanozolol [USAN:BAN:INN:JAN]
Stanozolol [USAN:USP:INN:BAN:JAN]
Stanozolol 1.0 mg/ml in Acetonitrile
Stanozolol powder
stanozolol--dea schedule iii
Stanozolol, analytical standard
Stanozolol, European Pharmacopoeia (EP) Reference Standard
Stanozololum
Stanozololum [INN-Latin]
Stromba
Strombaject
Tevabolin
TL8000176
Tox21_113993
UNII-4R1VB9P8V3
W-108823
WIN 14833
WIN-14833
Winstroid
Winstrol (TN)
Winstrol Depot
Winstrol V
Winstrol-V
Winstrol|||Stanabol
Z1541662177
ZINC4097376

US Patents and Regulatory Information for WINSTROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Inc WINSTROL stanozolol TABLET;ORAL 012885-001 May 14, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Moodys
Colorcon
Daiichi Sankyo
Teva
McKesson
Fish and Richardson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.